Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hazard Ratio01:12

Hazard Ratio

116
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
116
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

163
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
163

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Machine learning-based prediction of mortality and hospitalization in diabetic patients with heart failure with preserved ejection fraction: the GUARDIAN-P risk score.

European heart journal. Digital health·2026
Same author

The Impact of GLP-1-Based Therapies on Cardiovascular Outcomes in Type 2 Diabetes: A Comprehensive Systematic Review and Network Meta-Analysis.

Diabetes, obesity & metabolism·2026
Same author

Cardiovascular-kidney-metabolic interplay in patients with atrial fibrillation receiving direct oral anticoagulants.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Diagnosis of Cardiac Amyloidosis on Echocardiography Using Artificial Intelligence.

Circulation. Cardiovascular imaging·2026
Same author

Artificial Intelligence-Enabled Echocardiographic Assessment of Right Ventricular Function.

medRxiv : the preprint server for health sciences·2026
Same author

LV Diastolic Dysfunction and Inappropriate LV Filling Pressure Escalation: The Core of Exercise Intolerance in Heart Failure.

Korean circulation journal·2025
Same journal

Stable, Progressive, and Acute Valve Syndrome in Severe Aortic Stenosis: Insights from the CURRENT AS Registry-2.

Journal of the American Heart Association·2026
Same journal

<i>LPA</i> Kringle IV Type-2 Genetic Variants Are Associated With Apolipoprotein (a) Size, Hypertension, and Nonfasting Glucose Levels.

Journal of the American Heart Association·2026
Same journal

Hemorrhagic Transformation Mediates Stress Hyperglycemia Effect on Functional Outcome in Minor Ischemic Stroke.

Journal of the American Heart Association·2026
Same journal

Mental Disorders After Cardiac Implantable Electronic Device Implantation in Young Individuals.

Journal of the American Heart Association·2026
Same journal

Hypertensive Disorders of Pregnancy Associated With Cerebral Small Vessel Disease Decades Later.

Journal of the American Heart Association·2026
Same journal

Neighborhood-Level Racial and Ethnic Residential Segregation and Incidence of Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis.

Journal of the American Heart Association·2026
查看所有相关文章

相关实验视频

Updated: Jun 28, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K

ELUCIDATE试验:一个单中心随机对照研究.

Jiun-Lu Lin1,2, Sung-Chen Liu1,2, Tze-Fan Liu2

  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine MacKay Memorial Hospital Taipei Taiwan.

Journal of the American Heart Association
|April 19, 2024
PubMed
概括
此摘要是机器生成的。

在2型糖尿病患者早期的达帕格利弗洛辛治疗改善了心脏重塑和功能. 这种-葡萄糖共运输体2抑制剂在预防糖尿病心肌病方面表现有前途.

关键词:
临床试验临床试验临床试验临床试验临床试验达帕格利弗洛辛 (Dapagliflozin) 是一种超声心电图 (Echocardiography) 是一种心声回声仪.葡萄糖携带载体2抑制剂2 型糖尿病 2 型糖尿病腹腔的重塑 腹腔的重塑

更多相关视频

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.3K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

505

相关实验视频

Last Updated: Jun 28, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.3K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

505

科学领域:

  • 心脏病学 心脏病学
  • 内分泌学 在内分泌学.
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 2型糖尿病 (T2D) 与心血管并发症风险增加有关.
  • 像达帕格利弗洛辛这样的-葡萄糖共运输体2 (SGLT2) 抑制剂是已确立的T2D治疗方法,并且已经显示出心脏和脏的益处.
  • 早期的达帕格利弗洛辛干预对T2D患者的左心室 (LV) 改造的影响没有先前存在的心血管疾病 (CVD) 尚不清楚.

研究的目的:

  • 调查早期达帕格利弗洛辛补充治疗对无症状2型糖尿病患者的LV重塑和心脏功能的影响.
  • 为了评估在达帕格利弗洛辛治疗后LV尺寸,质量和应变参数的变化.
  • 评估达帕格利弗洛辛在糖尿病心肌病的初级预防中的潜力.

主要方法:

  • ELUCIDATE试验是一项前性,开放性,随机化研究,涉及76名无症状T2D患者,并保留了LV射出分数 (≥50%).
  • 患者被随机分配,接受达帕格利弗洛辛10毫克/天的补充疗法或标准护理.
  • 斑点跟踪回声心脏学被用来测量心脏全球纵向应变在基线和24周.

主要成果:

  • 与标准治疗相比,达帕格利弗洛辛治疗导致LV维度,LV末缩体积和LV质量指数显著减少.
  • 接受达帕格利弗洛辛治疗的患者显示,LV全球纵向应变率显著增加,并改善了心缩和早期心缩应变率.
  • 6个月后,没有观察到胰岛素耐药性,NT-proBNP水平或其他生物标志物的显著变化.

结论:

  • 早期的达帕格利弗洛辛补充疗法促进了有利的心脏重塑,并在无症状的2型糖尿病患者中增强了心脏机械功能.
  • 这些发现支持使用达帕格利弗洛辛作为糖尿病心肌病的主要预防方法.
  • 在T2D患者中,达帕格利弗洛辛甚至在明显的心血管疾病发作之前,也可能对心脏产生保护作用.